Expert Review of Hematology

Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice. Areas covered include: • Acute leukemias • Anemias • Bleeding disorders • Bone marrow and hematopoietic stem cell transplantation • Cellular disorders • Chronic leukemias • Disorders of iron metabolism • Hodgkins disease • Infection in hematology • Immunodeficiency syndromes • Autoimmune diseases • Marrow failure syndromes • Multiple myeloma and amyloidosis • Neutropenia • Non-Hodgkin lymphomas • Pediatric hematology • Platelet disorders • Thrombosis and hemostasis • Transfusion medicine Expert Review of Hematology provides commentary and analysis to elucidate best clinical practice in hematology and to translate advances in research – in areas such as immunology, stem cell research, and cell and gene therapy – into the clinical context.